The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property & Equity Holdings Pvt Ltd & PACs
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The promoter group of Suven Life Sciences, led by Jasti Property & Equity Holdings Pvt Ltd (sole trustee of the Jasti Family Trust) along with PACs, has acquired 3,17,68,764 equity shares on 6 March 2026. The shares were allotted on a preferential basis upon conversion of fully paid warrants. As a result, the promoter group's total holding increased from 15,32,31,236 shares (66.06% of equity capital) to 18,50,00,000 shares (70.15% of equity capital), a rise of about 4.17 percentage points. The company's total equity share capital expanded from 23.19 crore to 26.37 crore shares following the allotment. The acquired shares are subject to lock-in as per SEBI ICDR Regulations.
This is a promoter-led capital infusion that strengthens promoter control to over 70% but does not bring fresh external capital — the shares came from converting existing warrants. Shareholders should note the increased promoter concentration, though the lock-in provides short-to-medium term stability.